COVID-19 and smoking

Nicotine and Tobacco Research

Volumn 22, Issue 9, 2020, Pages 1650-1652

  Berlin, Ivan ^a,b   Thomas, Daniel ^a   Le Faou, Anne Laurence ^c   Cornuz, Jacques ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL PEPTIDASE IV; NICOTINE;

ACE2 GENE; CASE STUDY; CHINA; CORONAVIRUS DISEASE 2019; DISEASE ASSOCIATION; DISEASE SEVERITY; DPP4 GENE; GENE EXPRESSION LEVEL; HUMAN; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; NOTE; PANDEMIC; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION LEVEL; PUBLIC HEALTH; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SMOKING; TOBACCO;

EID: 85083207978     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntaa059     Document Type: Note

References (14)

1. Strzelak A, Ratajczak A, Adamiec A, Feleszko W. Tobacco smoke induces and alters immune responses in the lung triggering inflammation, allergy, asthma and other lung diseases: a mechanistic review. Int J Environ Res Public Health. 2018;15(5):1033.
2. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China [published online ahead of print, February 28, 2020]. N Engl J Med. 2020. doi:10.1056/NEJMoa2002032
3. Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China [published online ahead of print, February 19, 2020]. Allergy. 2020. doi:10.1111/all.14238
4. Liu W, Tao ZW, Lei W, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease [published online ahead of print, February 28, 2020]. Chin Med J. doi:10.1097/CM9.0000000000000775
5. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published online ahead of print, March 11, 2020; published correction appears in Lancet, March 12, 2020]. Lancet. 2020;395(10229):P1054-1062. doi:10.1016/S0140-6736(20)30566-3
6. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet, January 30, 2020]. Lancet. 2020;395(10223):497-506.
7. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [published online ahead of print, February 24, 2020; published correction appears in Lancet Respir Med., February 28, 2020]. Lancet Respir Med. 2020. doi:10.1016/ S2213-2600(20)30079-5
8. Vardavas CI, Nikitara K. COVID-19 and smoking: a systematic review of the evidence. Tob Induc Dis. 2020;18:20. doi:10.18332/tid/119324
9. Lippi G, Henry BM. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19) [published online ahead of print]. Eur J Intern Med. 2020. S0953-6205(20)30110-2. doi:10.1016/j.ejim.2020.03.014
10. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004;164(20):2206-2216.
11. Nam HS, Park JW, Ki M, Yeon MY, Kim J, Kim SW. High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea. Int J Infect Dis. 2017;58:37-42. doi:10.1016/j. ijid.2017.02.008
12. Alraddadi BM, Watson JT, Almarashi A, et al. Risk factors for primary middle east respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014. Emerg Infect Dis. 2016;22(1):49-55.
13. Seys LJM, Widagdo W, Verhamme FM, et al. DPP4, the Middle East respiratory syndrome coronavirus receptor, is upregulated in lungs of smokers and chronic obstructive pulmonary disease patients. Clin Infect Dis. 2018;66(1):45-53.
14. Cai G. Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov. medRxiv. 2020:2020.02.05.20020107. doi:10.1101/2020.02.05.20020107